EECO2 delivering over £10 million in global energy savings to Pharmaceutical & Life Sciences Energy marketplace

Mon, Apr 30, 2012 16:43 CET

Leading Energy Efficiency Consultancy EECO2 has delivered over £10 million in global energy savings since they began trading just 5 years ago.

The energy savings are displayed on their website at www.eeco2.co.uk . The savings delivered to date amount to an astounding 250,000kWh and 91,000 Co2 tonnes. EECO2 have firmly established their position as a leading consultancy within the pharmaceutical and life sciences sector and work with global giants such as GSK, AstraZeneca, Pfizer, Lilly and Novartis.

Founding Director Rob Wallace said:

“The core expertise & experience within EECO2 is not the usual ‘Consultant’ format as we all come from a design & build background, commercially grounded and totally focused upon the identification & cost effective delivery of identified energy savings. We validate energy savings and are able to demonstrate over £10 million in savings to date”

EECO2 use their acquired experience & knowledge to provide cost effective, energy & emission reduction solutions from initial opportunity identification through implementation & verification of savings. The Pharmaceutical Industry is heavily regulated. Historically HVAC was over designed with subsequent high running costs and carbon intensive facilities, exceeding levels required for compliance. As a result, facilities are operating in excess of the levels required for compliance at an ever increasing cost due to energy price rises.

Energy Experts at EECO2 have identified the following key challenges for the pharmaceutical sector;

The need to compete with low cost manufacturers
The need to provide affordable high quality medicines to a global market place
The need to maintain profitability
The need to reduce carbon emissions
The need to respond to energy and carbon reduction legislation

To remain competitive, pharmaceutical companies can no longer afford to continue to run over compliant facilities that add no additional benefits to product quality. The EECO2 approach relies on identifying and reducing energy demand without compromising on product quality. The key to this requires the complete involvement of their clients’ key stakeholders; Engineering, Manufacturing, Quality Assurance, Health and Safety.

EECO2 offer the following services to the global pharmaceutical sector: